Equities

Kilitch Drugs (India) Ltd

KILITCH:NSI

Kilitch Drugs (India) Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)388.90
  • Today's Change-0.70 / -0.18%
  • Shares traded17.35k
  • 1 Year change+177.79%
  • Beta1.0784
Data delayed at least 15 minutes, as of Mar 28 2024 10:13 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Kilitch Drugs (India) Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in developing, manufacturing and marketing a range of pharmaceutical formulations. The Company’s products include Parenteral and Nasal Products, Oral, Effervescent, Nutritional Products, Medical Devices, and Cosmetics and Herbal Products. Its Parenteral and Nasal Products has a range of products that help in gastroenterology, anti-inflammatory, anti-malaria, diagnostic, uterine stimulants, veterinary and other areas in the form of ampoules and vials. Its range of oral formulations includes tablets, capsules, dry syrups and oral powders. It provides a range of cosmetics ranging from oil, lotion, liquid to cream and paste in the skin care, personal care and hair care categories. Its herbal products are useful for sore throat, prostate problems, and can be used as supplements for diabetes, obesity, libido and others. Its medical devices offer a C-Seal brand.

  • Revenue in INR (TTM)1.55bn
  • Net income in INR145.71m
  • Incorporated1992
  • Employees153.00
  • Location
    Kilitch Drugs (India) LtdVillage: SavroliTaluka: Khalapur, Dist: RaigadMUMBAI 400088IndiaIND
  • Phone+91 2 261214100
  • Fax+91 2 267031658
  • Websitehttps://www.kilitch.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Zim Laboratories Ltd3.55bn163.97m4.63bn525.0028.25--13.861.303.363.3672.78--------6,761,375.00--3.96--7.0053.5747.554.623.93--4.08--2.4919.527.7667.935.045.16--
Wanbury Ltd5.69bn233.39m4.79bn1.58k20.54--13.240.84137.127.12173.80--------3,598,099.00--6.56----46.1543.924.104.54--1.82-----2.265.95-112.76--34.73--
Medicamen Biotech Ltd1.71bn126.93m4.88bn388.0039.25--26.872.869.789.78131.89--------4,398,250.00--7.17--10.4446.8833.856.5810.87--4.76--8.6122.024.77-0.35557.98-4.210.00
IND Swift Laboratories Ltd11.92bn431.95m5.92bn1.50k13.68--6.320.49657.327.32201.78--------7,966,648.00--0.5374--0.683947.6040.863.671.08--2.27--0.0016.239.542,314.8316.71-9.61--
Albert David Ltd3.55bn662.42m6.15bn1.27k9.28--8.361.73116.07116.07621.75--------2,791,696.00--7.61--10.1764.3360.2118.678.47--108.22--16.188.953.402.6021.826.8110.35
Kilitch Drugs (India) Ltd1.55bn145.71m6.25bn153.0042.21--38.774.039.219.2198.24--------10,132,730.00--2.63--3.5939.6833.858.255.01--3.43--2.9322.2022.3041.8215.191.79--
Valiant Laboratories Ltd-100.00bn-100.00bn6.30bn--------------------------------------------------60.35--27.66------
Nectar Lifesciences Ltd16.32bn80.79m6.76bn1.59k82.63--9.810.41430.36490.364974.40--------10,271,550.00--0.0556--0.103827.4015.630.4950.0707--0.7366--32.09-8.70-4.33-196.55---1.95--
Jagsonpal Pharmaceuticals Ltd2.21bn245.16m7.29bn940.0029.74--27.733.309.309.3083.51--------2,347,522.00--10.02--12.5154.0958.4711.118.03--30.39--36.248.7913.3341.72---39.20118.67
Panacea Biotec Ltd5.52bn-119.17m7.45bn1.09k----14.471.35-1.89-1.8989.86--------5,046,990.00--10.52--18.6556.8850.87-2.2127.34------0.00-30.44-5.06-103.08--21.89--
Sakar Healthcare Ltd1.51bn124.73m8.01bn297.0060.37--27.425.316.106.1073.58--------5,082,286.00--6.35--7.5946.1844.288.2610.84--2.40----4.0020.23-16.3027.3156.31--
Bajaj Healthcare Ltd4.98bn212.66m8.07bn1.06k37.91--16.461.627.71-18.22180.50--------4,684,510.00--9.86--17.4242.2626.474.278.57--1.66-----0.970415.53-39.7323.1660.8231.95
Data as of Mar 28 2024. Currency figures normalised to Kilitch Drugs (India) Ltd's reporting currency: Indian Rupee INR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.